elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Myelodysplastic syndromes
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Myelodysplastic syndromes
RIS
0.001
(Research Intensity Score)
Papers
80
Top papers
Role of reactive oxygen species in myelodysplastic syndromes
2024 · 29 citations
Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study
2020 · 211 citations
Linking Air Pollution and Hematologic Malignancies: From Epidemiology to Molecular Mechanisms
2026
Severe Lead Toxicity Simulating Myelodysplastic Neoplasm: A Case Report
2026
Chronic Myelomonocytic Leukemia: History, Pathobiology, Diagnostic Controversies, and Evolving Classification
2026
Complex Karyotype and TP53 Alterations in AML and MDS
2026
Peptide–Drug Conjugates for Targeted Delivery in Hematological Malignancies: From Design Principles to Clinical Application
2026
Genomic landscape, clinical correlates and prognostic implications of U2AF1 mutation subtypes in myelodysplastic neoplasms
2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax—an analysis from the International Consortium for MDS (icMDS) VALIDATE database
2026
Newest papers
Linking Air Pollution and Hematologic Malignancies: From Epidemiology to Molecular Mechanisms
2026
Severe Lead Toxicity Simulating Myelodysplastic Neoplasm: A Case Report
2026
Chronic Myelomonocytic Leukemia: History, Pathobiology, Diagnostic Controversies, and Evolving Classification
2026
Complex Karyotype and TP53 Alterations in AML and MDS
2026
Peptide–Drug Conjugates for Targeted Delivery in Hematological Malignancies: From Design Principles to Clinical Application
2026
Genomic landscape, clinical correlates and prognostic implications of U2AF1 mutation subtypes in myelodysplastic neoplasms
2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax—an analysis from the International Consortium for MDS (icMDS) VALIDATE database
2026
Therapy-related myeloid neoplasms after radioligand therapy in neuroendocrine tumors: A multicenter real-world analysis.
2026
Clonal hematopoiesis-related outcomes associated with radioligand therapy in prostate cancer: A “real-world” analysis.
2026
Browse all papers →
Myelodysplastic syndromes's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Myelodysplastic syndromes's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link